ORMP
Oramed Pharmaceuticals, Inc

4,681
Mkt Cap
$144.88M
Volume
76,899.00
52W High
$3.67
52W Low
$1.82
PE Ratio
3.63
ORMP Fundamentals
Price
$3.64
Prev Close
$3.39
Open
$3.43
50D MA
$2.80
Beta
0.67
Avg. Volume
160,891.68
EPS (Annual)
-$0.4668
P/B
0.73
Rev/Employee
$0.00
News
all
press releases
News Placeholder
Oramed and Lifeward Announce Strategic Transaction
Oramed and Lifeward Announce Strategic Transaction Oramed and Lifeward Announce Strategic Transaction PR Newswire NEW YORK, Jan. 13, 2026 Transaction Will TransferOramed's Oral Drug Delivery Platform...
PR Newswire·2d ago
News Placeholder
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Oramed Reports Fiscal Third Quarter 2025 Financial Results Oramed Reports Fiscal Third Quarter 2025 Financial Results PR Newswire NEW YORK, Nov. 17, 2025 Strong Nine-Month Performance Driven by...
PR Newswire·2mo ago
News Placeholder
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS PR Newswire NEW...
PR Newswire·2mo ago
News Placeholder
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives Oramed Releases Letter to...
PR Newswire·3mo ago
<
...
1
>

Latest ORMP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.